158 filings
Page 5 of 8
DEF 14A
LTRN
Lantern Pharma Inc
9 Apr 21
Definitive proxy
11:30am
10-K
2020 FY
LTRN
Lantern Pharma Inc
10 Mar 21
Annual report
4:07pm
8-K
LTRN
Lantern Pharma Inc
10 Mar 21
Lantern Pharma Reports Fourth Quarter and Year End 2020
4:02pm
SC 13G
LTRN
Lantern Pharma Inc
16 Feb 21
Lantern Pharma / Green Park & Golf Ventures ownership change
4:02pm
SC 13G
Arunkumar Asaithambi
16 Feb 21
Lantern Pharma / Asaithambi Arunkumar ownership change
1:15pm
SC 13G
LTRN
Lantern Pharma Inc
25 Jan 21
Lantern Pharma / Empery Asset Management ownership change
9:41am
4
Lantern 3-19 Investment, LLC
19 Jan 21
Lantern Pharma / Carl D Soderstrom ownership change
6:16pm
424B4
LTRN
Lantern Pharma Inc
15 Jan 21
Prospectus supplement with pricing info
5:24pm
S-1MEF
LTRN
Lantern Pharma Inc
15 Jan 21
Registration of additional securities for an S-1
6:03am
EFFECT
LTRN
Lantern Pharma Inc
15 Jan 21
Notice of effectiveness
12:15am
FWP
LTRN
Lantern Pharma Inc
11 Jan 21
Free writing prospectus
6:08am
CORRESP
LTRN
Lantern Pharma Inc
11 Jan 21
Correspondence with SEC
12:00am
S-1
LTRN
Lantern Pharma Inc
IPO registration
8 Jan 21
5:10pm
CORRESP
LTRN
Lantern Pharma Inc
8 Jan 21
Correspondence with SEC
12:00am
8-K
LTRN
Lantern Pharma Inc
6 Jan 21
Entry into a Material Definitive Agreement
3:44pm
UPLOAD
LTRN
Lantern Pharma Inc
21 Dec 20
Letter from SEC
12:00am
DRS
LTRN
Lantern Pharma Inc
16 Dec 20
Draft registration statement
12:00am
DRSLTR
LTRN
Lantern Pharma Inc
15 Dec 20
Correspondence regarding draft registration statement
12:00am
10-Q
2020 Q3
LTRN
Lantern Pharma Inc
Quarterly report
29 Oct 20
4:00pm
8-K
LTRN
Lantern Pharma Inc
29 Oct 20
Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational Progress
3:59pm